RFX2 activators are a specialized class of chemical compounds designed to enhance the functional activity of the Regulatory Factor X2 (RFX2) protein, which plays a crucial role in transcriptional regulation, particularly in the context of ciliogenesis and spermatogenesis. The activation of RFX2 is not brought about through direct binding interactions with these compounds but rather through the modulation of signaling pathways and cellular processes that RFX2 is intrinsically a part of. These activators work by influencing a range of upstream signaling molecules, transcriptional co-regulators, and chromatin remodeling complexes that converge on the enhancement of RFX2's transcriptional activity. For example, compounds that modulate the cellular redox state can indirectly affect RFX2 by altering the oxidation-sensitive transcription factors that interact with RFX2 to co-regulate gene expression. By maintaining an optimal redox environment, such activators can enhance RFX2's ability to participate in the transcriptional regulation of genes implicated in cell cycle progression and ciliary function.
Additionally, certain RFX2 activators may target pathways involved in the phosphorylation status of associated proteins, thus indirectly modifying RFX2 activity. These activators may work by inhibiting phosphatases that would otherwise dephosphorylate RFX2 or its cofactors, thereby maintaining RFX2 in a state that is conducive to binding DNA and activating gene transcription. Other compounds in this class might upregulate cellular levels of secondary messengers, such as cAMP, which subsequently activate protein kinases that can phosphorylate co-regulatory proteins, leading to a synergistic enhancement of RFX2-mediated transcription. Collectively, RFX2 activators exert their effects through a complex network of intracellular signaling cascades, ensuring that RFX2 is fully competent to execute its role in the precise temporal and spatial expression of genes necessary for cellular differentiation and function, particularly in the context of ciliary assembly and sperm development, without directly increasing its expression levels or altering its inherent DNA-binding specificity.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, leading to the activation of PKA, which can phosphorylate RFX2, enhancing its transcriptional activity on cAMP-responsive genes. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which increases cAMP levels and subsequently activates PKA, potentially increasing the phosphorylation and activity of RFX2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can lead to the downstream phosphorylation and enhancement of RFX2 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially modulating calcium-sensitive pathways that could enhance RFX2 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, potentially impacting calcium/calmodulin-dependent kinase pathways that enhance RFX2 activity. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromoadenosine 3',5'-cyclic monophosphate is a cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of RFX2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This catechin inhibits several protein kinases, likely altering signaling pathways that could lead to an enhancement of RFX2's functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which may shift signaling balances in the cell and indirectly enhance RFX2 activity through compensatory pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is another MEK inhibitor, which may similarly derepress pathways or proteins that enhance RFX2 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which could lead to increased phosphorylation states of proteins including RFX2, enhancing its activity. | ||||||